tiprankstipranks
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
US Market
IDYA
IDEAYA Biosciences
RESEARCH TOOLSreports
Want to see IDYA full AI Analyst Report?

IDEAYA Biosciences (IDYA) Stock News & Sentiment

665 Followers
IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial
Premium
Company Announcements
IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial
22d ago
8K
IDYA
IDEAYA Biosciences: Operational Trial Delay but High Conviction Buy Ahead of Key Darovasertib Readout
Premium
Ratings
IDEAYA Biosciences: Operational Trial Delay but High Conviction Buy Ahead of Key Darovasertib Readout
1M ago
IDYA
IDEAYA Biosciences: Expanding Precision Oncology Platform and Refocused MTAP Strategy Support Buy Rating
Premium
Ratings
IDEAYA Biosciences: Expanding Precision Oncology Platform and Refocused MTAP Strategy Support Buy Rating
2M ago
IDYA
IDEAYA Biosciences: Methodologically De-Risked OpTimUM-02 Readout and Strong Cash Runway Support Buy Rating
Premium
Ratings
IDEAYA Biosciences: Methodologically De-Risked OpTimUM-02 Readout and Strong Cash Runway Support Buy Rating
2M ago
IDYA
IDEAYA Biosciences: Pipeline Progress and Late-Stage Clinical Expansion Support Reiterated Buy Rating
Premium
Ratings
IDEAYA Biosciences: Pipeline Progress and Late-Stage Clinical Expansion Support Reiterated Buy Rating
2M ago
IDYA
IDEAYA Biosciences: Buy Rating on Darovasertib/Crizotinib Ahead of Pivotal OpतimUM-02 Readout and Supported by Strong Cash Runway
Premium
Ratings
IDEAYA Biosciences: Buy Rating on Darovasertib/Crizotinib Ahead of Pivotal OpतimUM-02 Readout and Supported by Strong Cash Runway
2M ago
IDYA
Multiple Shots on Goal in High-Unmet-Need Oncology: IDEAYA’s Diversified Pipeline and Strong Funding Underpin Buy Rating
Premium
Ratings
Multiple Shots on Goal in High-Unmet-Need Oncology: IDEAYA’s Diversified Pipeline and Strong Funding Underpin Buy Rating
4M ago
IDYA
More IDYA News >

IDYA News on the Web

Analysts’ Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Ideaya Biosciences price target raised to $58 from $52 at Wedbush
TipRanks News
Bullish
Ideaya Biosciences price target raised to $54 from $50 at Guggenheim
TipRanks News
Bullish
IDEAYA Biosciences (IDYA) Receives a Hold from Goldman Sachs
TipRanks News
Neutral
Wells Fargo Remains a Buy on IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Ideaya Biosciences price target raised to $53 from $49 at RBC Capital
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON) and IDEAYA Biosciences (IDYA)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), IDEAYA Biosciences (IDYA) and Ligand Pharma (LGND)
TipRanks News
Neutral

News Score - Last 7 Days

Positive
IDYA
Sector Average
Media Buzz
This Week8 articles
Weekly Average9.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IDYA’s Media Buzz Sentiment?
8 articles about IDYA were published this week. In an average week, 9.75 articles are published.
    What is IDYA’s weekly average amount of articles?
    In an average week, 9.75 articles about IDYA are published.
      What is IDYA’s News Sentiment?
      100% of articles about IDYA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week